An overview of cervical cancer epidemiology and prevention in the Baltic States

[21] Bruni L(2018)Trends in cervical cancer mortality rates in Lithuania, 1987–2016 Cancer Epidemiol 57 85-8

[22] Uusküla A(2019)Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis Lancet 394 497-51

[23] Kals M(2020)HPV Vaccination and the risk of Invasive Cervical Cancer N Engl J Med 383 1340-81

[24] Kosenkranius L(2018)Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action Papillomavirus Res 5 21-undefined

[25] Kulmala SM(2018)Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination BMC Public Health 18 1360-undefined

[26] Shabalova IP(2021)Post-reproductive aged women: a lost generation in the cervical cancer screening programme Eur J Contracept Reprod Health Care 26 23-undefined

[27] Petrovitchev N(2011)Women’s knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia BMC Womens Health 11 43-undefined

[28] Kliucinskas M(2018)Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014 BMC Cancer 18 1075-undefined

[29] Nadisauskiene RJ(2015)Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries Eur J Cancer 51 241-undefined

[30] Minkauskiene M(2002)Benefits and costs of using HPV testing to screen for cervical cancer JAMA 287 2372-undefined

[21] Bruni L(2018)Trends in cervical cancer mortality rates in Lithuania, 1987–2016 Cancer Epidemiol 57 85-8

[22] Uusküla A(2019)Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis Lancet 394 497-51

[23] Kals M(2020)HPV Vaccination and the risk of Invasive Cervical Cancer N Engl J Med 383 1340-81

[24] Kosenkranius L(2018)Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action Papillomavirus Res 5 21-undefined

[25] Kulmala SM(2018)Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination BMC Public Health 18 1360-undefined

[26] Shabalova IP(2021)Post-reproductive aged women: a lost generation in the cervical cancer screening programme Eur J Contracept Reprod Health Care 26 23-undefined

[27] Petrovitchev N(2011)Women’s knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia BMC Womens Health 11 43-undefined

[28] Kliucinskas M(2018)Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014 BMC Cancer 18 1075-undefined

[29] Nadisauskiene RJ(2015)Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries Eur J Cancer 51 241-undefined

[30] Minkauskiene M(2002)Benefits and costs of using HPV testing to screen for cervical cancer JAMA 287 2372-undefined